{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-012673","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.656679+00:00","generated_at":"2026-05-15T08:58:24.169365+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dyadic reports FY 2025 net loss of $7.36M; revenue down to $3.09M","bullets":["Cash and securities of $8.59M as of Dec 31, 2025, down from $9.29M a year earlier.","Revenue fell to $3.09M from $3.50M; net loss widened to $7.36M ($0.23/sh) from $5.81M ($0.20/sh).","Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant; Dyadic eligible for profit share.","Expanded Fermbox Bio collaboration; commercial launch of recombinant DNase I (RNase-free).","OEM distribution agreement with IBT Bioservices for DNase I and transferrin; BRIG Bio deal for alpha-lactalbumin."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-012673","json":"https://secwatch.observer/filing/0001493152-26-012673.json","markdown":"https://secwatch.observer/filing/0001493152-26-012673.md","text":"https://secwatch.observer/filing/0001493152-26-012673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/0001493152-26-012673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:58:24.169365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6af2f6d72f1f90e6b9b5b8dbffa2937a2b1c45eb","claim":"DYADIC INTERNATIONAL INC reported financial results for the year ended December 31, 2025.","evidence_excerpt":"On March 25, 2026, Dyadic International, Inc. (“Dyadic”) issued a press release announcing its results for the year ended December 31, 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/0001493152-26-012673-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2025"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}